Trading Summary - December 13. More upwards progress

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
204
Trading Summary - December 13.

More upwards progress today - another tick to .0028 hod and recent high..

When the ask was not hit aggressively enough, the scammer / shorter tried his usual trick of shorting to .0019 below multiple extant bids in the .0020 > .0026 range.

Any undercut asks below hod .0028 were bought out immediately.

Some of the .0028 ask remaining was cancelled at the close.

Overall, another 3.3M shares were bought today at bottom prices in the same broad range .0020 > .0052 (most of it at .0026 > .0028 today) as makes little difference at .01 > .02+. As predicted, top long term traders are more likely to buy 1M+ at each price point at current levels rather than 100K > 200K - and were seen to do so.

Since the loading at bottom prices total was restarted after the last run, 635.7M shares have been bought up to .0052 in 58 trading days September 22 - December 13 - 76% of the low Unrestricted Outstanding Shares count.

New interest traders / alerters + long-term traders with significant followings as at December 12 numbered at least 132 - up another 6 in the previous 7 days. List here:

https://investorshangout.com/post/view?id=6299730

Particular points they like are:

- Real revenue of $10M+ per year.

- Operating profit achieved in Q3.

- $49K in cash available for inventory purchases.

- Assets of $1.398M.

- Low Unrestricted O/S of 837M - with none added in the last 3+ months.

- Public Offering of 1.85 Billion shares cancelled - no longer required.

- How thin it is into the .01 > .02 range.

On the next run over .01, the degree to which $SFLM penetrates up towards .02+ will depend on how many of these new followers take profits above .01.

Either way, longs who follow my strategy will be keeping their core holding for the OTCQB uplisting - which will require sustaining prices above a .01 bid - and also some for when all 9 elements reach the same revenue level anticipated by the CEO. Trading some on every surge allows a larger core to be held on a cost basis that is essentially "free" - already paid for by banked profits.

The correct market cap price for the anticipated revenue as income ramps up under the Collectibles Marketplace Strategy would be in the .062 > .1075 range in future years when they manage to get all 9 elements in the plan to the performance level of the existing SFLMaven eBay business (plus remember more platforms coming as well).

On $SFLM, the larger the inventory of shares acquired below .0050, the more that will be available to trade for 100% to 400% in the .01 > .0150 range on the next run to that level - whenever that may be - whilst also retaining a significant core converted to free for OTCQB uplisting and the planned 8 x 2021 revenue under the Collectibles Marketplace Strategy.

Remember that the price difference between .0020 and .0050 is irrelevant when traded at .01 > .02+ - let alone at .062 > .1075.

Every 1M bought at .0030 is worth a $7K profit at .01, $10K profit at .0130 and $17K profit at .02.

Every 1M bought at .0050 is worth a $7K profit at .0120, $10K profit at .0150 and $15K profit at .02.

Every 1M bought at .0050 is worth a $57K profit at .074 or $102.5K profit at .1075.

All that matters is who got where - charts are irrelevant - and denying as many shares under .01 as possible to the institutional level new interest that PRs + improving financials + MZ Group though investor symposiums are expected to bring in over the days, weeks and months ahead in 2022.

Latest DD - updated December 12 - here:

https://investorshangout.com/post/view?id=6299750

The anticipated revenue in 2021 - based on pro-rata of sales to date - is $10M+.

Additional inventory on the 1stDibs store at "BuyItNow" prices total of $331K.

$SFLM remains my #1 Top Profit Pick for the whole of 2021 and for me is currently #2 - flip flopping #1 - behind only $ENZC - due to the regular periodic surges.

It will now also be the #1 or #2 Top Profit Pick for the whole of 2022 (depending on $ENZC developments in the next 2 months).

I will not necessarily be doing a trading summary every day - unless there are undue manipulation attempts - as the ticker is firmly under control and just awaiting the next run into the .01 > .02 range.

iHub has been deliberated marginalized due to time-wasting nonsense there with all serious interest successfully directed to here over the last several months - with typically 500 > 700+ views per day - and repeated where interest in "real" companies is known to exist.

Nationwide expansion of the NFT Division continued on October 19 with the sign-up of a second regional based artist.

Also bear in mind that Q4 is traditionally the best Q each year due to Christmas shopping and supply chain issues in brick and mortar stores forcing more people to consider on-line purchases in good time.

The 2021 Q3 was filed after the close on November 15 - it was in line with the expectations of the top trader close followers of $SFLM with increased sales, increased gross profit, increased assets and vastly increased cash available for inventory purchase. Most importantly, the cash flow actually flipped positive for the first time ever - in Q3 rather than Q4 - where Q4 will obviously be even better than Q3.

2021 Q3 Key Points here:

https://investorshangout.com/post/view?id=6283945

Watch for the next PR soon which I would expect to cover the excellent Q3 results, the sales since in October and November, and any developments from the CEO attending a NFT / crypto expo in Miama.

The Share Structure was updated after the close on December 7 - again showing no change and confirming no dilution - with the Unrestricted O/S remaining at a low 837M.

I added more batches today - on the ask and on the bid - and will continue to do so - both countering the manipulation attempts from the scammer(s) and buying up shares from the impatient.


SFLMaven, Inc. (SFLM) Stock Research Links

SFLM Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

American Lung Association's Bold $21M Research Investment

Updated Category News Views 56

Pumping Life into Lung Health Research The American Lung Association (ALA) just announced a jaw-dropping $21 million investment this year into lung health research. That's right, while some are counting beans, ALA is diving headfirst into serious health challenges plaguing millions of Americans. They've pumped hundreds of millions in the past decade, totaling $193...

Continue Reading
Florida's Natural, Johnsonville Settle Bet Over Juice

Updated Category News Views 103

No Such Thing as a Safe Bet When Milwaukee's Brewers edge out Tampa, it's not just about the wins and losses—it's about pride and a truckload of Florida's Natural orange juice cruising into Wisconsin. Who knew baseball could drive trades not just between players, but entire industries? In this friendly wager, the stakes were both flavorful and steep, paying homage to...

Continue Reading
Ashling's New Feat: Microsoft Recognition in AI

Updated Category News Views 122

Microsoft's Stamp of Approval for Ashling Ah, recognition—it's not just for egos. When Ashling, an AI consultancy heavyweight, gets a nod from Microsoft, it's worth more than a footnote in the company newsletter. This isn't some participation trophy. Nope, it's a badge saying they know their Data & AI, and Digital & App Innovation inside out. On October 29, 2026,...

Continue Reading
Intestinal Worms: New Science and Old Challenges

Updated Category News Views 0

Intestinal Worms: A Modern Twist on an Old Tale Just when you thought you'd heard it all, here comes the notion that intestinal worms might actually be good for us. The stuff of cringe-worthy junior high biology classes is now strutting its stuff in F1000Research. Sounds odd? Maybe, but there's a half-century of science behind it. Old Foes with New Friends These...

Continue Reading
BJ's Brews a New Dessert Innovation with Pizookie

Updated Category News Views 76

Banana Bread Meets Nutella in BJ's Latest Pizookie Right off the bat, let's cut to the heart of this dessert innovation. BJ's Restaurant & Brewhouse, traded under NASDAQ:BJRI, has fired up its dessert menu with something new: the Nutella® Gone Bananas Pizookie®. This isn't just another sweet treat—it’s a bold move, and if you're wondering why, you're in good...

Continue Reading
McKay Brothers Enhances Fastest Routes for Market Data

Updated Category News Views 130

Breaking Down McKay Brothers' Latest Maneuver Yeah, the financial market isn't just numbers and screens—it's about moving those numbers faster than a cheetah chasing prey. McKay Brothers knows this game inside and out, and they're laying down new wires, or rather, wireless, to make sure they've got the quickest routes in the room. Let me tell you, they're throwing money...

Continue Reading
Hehe Culture's Timeless Wisdom Explored at Forum

Updated Category News Views 0

Hehe Forum: Bridging the Past and Present Sometimes, the past isn't just anchor weight, it's a compass guiding us through the murky waters of today. The Hehe Culture Forum's latest gathering in Tiantai County, Zhejiang Province, aimed to unravel just how much ancient wisdom can still steer the course in this fast-changing world. Delegates from 23 nations joined forces,...

Continue Reading
Stora Enso Plans Bold Demerger; Bergslagets Skogar to List

Updated Category News Views 84

Stora Enso's Strategic Split: Bold Move or Risky Bet? There's something almost audacious about Stora Enso's decision to separate Bergslagets Skogar into its own publicly listed company. The board has given this demerger plan the green light, aiming to unravel a more refined operation out of Stora Enso's labyrinthine portfolio. It's a move that should have the suits on...

Continue Reading
Skechers Faces Shareholder Lawsuit: Must Act by Dec 21

Updated Category News Views 45

Skechers Shareholders Stirring Over Lawsuit A fresh wave of legal antics is crashing at the shores of Skechers U.S.A., Inc. (NYSE: SKX) as frustrated shareholders mobilize against the footwear juggernaut. We're talking about a class action lawsuit here, folks, aimed at shaking down some clarity—or maybe just some cold, hard cash—from this bruiser over some sketchy...

Continue Reading
KLC's TTV Solutions Power Up AI and EV Innovation

Updated Category News Views 18

Thermal Management: The Unsung Hero When it comes to pushing the boundaries of AI and electric vehicles (EVs), it's the behind-the-scenes tech that counts. KLC Corporation of Taiwan throws the spotlight on their Thermal Test Vehicle (TTV) solutions, proving that heat management isn't just a necessary evil—it's a competitive advantage. KLC's Role in the Semiconductor...

Continue Reading

Top 5 Most Recently Viewed Articles

Recover Your Losses with Unicycive Therapeutics Class Action

Updated Category News Views 113

Join the Class Action Suit for Unicycive Therapeutics Shareholders The Gross Law Firm is reaching out to shareholders of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) regarding a class action lawsuit. If you have acquired shares during the specified class period, it is crucial that you understand your rights and the steps available for potential recovery of your...

Continue Reading
F1® Arcade Launches Exciting Venue at The Interlock in Atlanta

Updated Category News Views 382

F1® Arcade Opens at The Interlock, a Premier Destination In a significant development, Armada Hoffler (NYSE: AHH) has completed a lease agreement with F1® Arcade, marking the arrival of the world’s first Formula 1® hospitality brand at The Interlock. This new venture occupies over 15,000 square feet of vibrant space in Atlanta’s West Midtown, achieving a remarkable...

Continue Reading
Oncotelic's Innovative Approach Boosts Cancer Treatment Landscape

Updated Category News Views 159

Pioneering New Frontiers in Cancer Treatment The field of cancer treatment is seeing transformative innovation as companies like Oncotelic Therapeutics Inc. (OTCQB: OTLC) leverage modern technology to tackle some of the most aggressive cancers and rare diseases. The urgency for new therapies is underscored by the continuing challenges posed by illnesses like glioblastoma...

Continue Reading
Revolutionizing Healthcare: CharmHealth’s Innovative Journey Forward

Updated Category News Views 363

CharmHealth's Commitment to Healthcare Innovation CharmHealth, a premier provider of healthcare technology solutions, has made significant strides in revolutionizing healthcare practices. With a thriving presence in the industry, it showcases a robust dedication to enhancing both provider and patient experiences through innovative solutions. As the demand for...

Continue Reading
U.S. Energy Corp. Celebrates Resilient Growth in Recent Reports

Updated Category News Views 138

U.S. Energy Corp's Exciting Journey Amid Market Challenges U.S. Energy Corporation (NASDAQ: USEG) recently announced commendable financial and operational results for the fourth quarter as well as the entire year ending in 2024. This energy company has focused on growing its value through effective asset management and strategic market operations. 2024: A Year of...

Continue Reading